☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
daratumumab
Janssen Reports sBLA Submission to the US FDA for Darzalex Faspro (daratumumab and hyaluronidase-fihj) to Treat Patients with Ligh...
September 11, 2020
The US FDA Approves Kyprolis (carfilzomib) + Darzalex (daratumumab) + Dexamethasone in Two Dosing Regimens for R/R Multiple Myelom...
August 21, 2020
Janssen's Darzalex (daratumumab- SC) Receives Health Canada Approval for the Treatment of Patients with Multiple Myeloma
August 4, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.